Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.
Anthony Calamunci, FisherBroyles, LLP
Advertisement
Articles by Anthony Calamunci, FisherBroyles, LLP
Legislation seeks to fight drug cost increases by creating transparency in the pricing activities of manufacturers and pharmacy benefit managers.
Advertisement
Latest Updated Articles
State-Level Diabetes Drug-Pricing Transparency Bills Target PBMsPublished: August 2nd 2017 | Updated:
Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims AllegationsPublished: August 9th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5
